Insulin resistance in dilated cardiomyopathy

Reviews in Cardiovascular Medicine

Volumn 4, Issue SUPPL. 6, 2003, Pages

  Shah, Ankur ^a   Shannon, Richard P ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Insulin resistance; Insulin signaling; Lipolysis; Nonesterified fatty acids; Sympathetic nervous system activation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE PALMITOYLTRANSFERASE; CARVEDILOL; COENZYME A; FATTY ACID; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; INSULIN; MALONYL COENZYME A; PEPTIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE; PROGLUCAGON; PROTEIN KINASE B; PROTEIN KINASE C; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ADRENERGIC SYSTEM; ATHEROSCLEROSIS; CONGESTIVE HEART FAILURE; DATA ANALYSIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART DILATATION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HIGH ENERGY PHOSPHATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL EDEMA; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

CARDIOMYOPATHY, DILATED; GLUCOSE; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN; INSULIN RESISTANCE; MYOCARDIUM; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0346271515     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Standl E, Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia. 2000;43:1455-1469.
2. Rubins HB, Robins SJ, Collins D, et al. Diabetes, plasma insulin and cardiovascular disease. Subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial [VA-HIT]. Arch Intern Med. 2002;162:2597-2604.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-359.
4. Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation. 2002; 106:2043-2045.
5. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I. general concepts. Circulation. 2002;105:1727-1733.
6. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: part II. potential mechanisms. Circulation. 2002;105:1861-1870.
7. Razeghi P, Young ME, Alcorn JL, et al. Metabolic gene expression in fetal and failing human heart. Circulation. 2001;104:2923-2931.
8. Osorio JC, Stanley WC, Linke A, et al. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation. 2002;106:606-612.
9. Davilia-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271-277.
10. Amato L, Paolisso G, Cacciatore F, et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab. 1997;23:213-218.
11. Suskin N, McKelvie RS, Burns RJ, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 2000;21:1368-1375.
12. Paolisso G, De Riu S, Marrazzo G, et al. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism. 1991;40:972-977.
13. Paolisso G, Tagliamonte MR, Rizzo MR, et al. Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease. Am J Cardiol. 1999; 83:1338-1344.
14. Coats AJ, Anker S. Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol. 2000;35(7 suppl 4):S9-S14.
15. Swan JW, Walton C, Godsland IF, et al. Insulin resistance in chronic heart failure. Eur Heart J. 1994;15:1528-1532.
16. Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527-532.
17. Doehner W, Anker SD, Coats AJ. Defects in insulin action in chronic heart failure. Diabetes Obes Metab. 2000;2:203-212.
18. Paternostro G, Camici PG, Lammerstma AA, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 1996;98:2094-2099.
19. Paternostro G, Pagano D, Gnecchi-Ruscone T, et al. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res. 1999;42:246-253.
20. Jagasia D, Whiting JM, Concato J, et al. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease. Circulation. 2001; 103:1734-1739.
21. Pitkanen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes. 1998;47:248-254.
22. Battilana P, Seematter G, Schneiter P, et al. Effects of free fatty acids on insulin sensitivity and hemodynamics during mental stress. J Clin Endocrinol Metab. 2001;86:124-128.
23. Boden G. Free fatty acids - the link between obesity and insulin resistance. Endocr Pract. 2001;7:44-51.
24. Hemmings BA, Brazil DP. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001;26:657-664.
25. Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses. J Cell Sci. 2001;114:2903-2910.
26. Hjemdhal F. Stress and the metabolic syndrome, an interesting but enigmatic association. Circulation. 2002;106:2634-2636.
27. Nonogaid K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 2000;43:533-549.
28. Wallhaus TR, Taylor M, DeGrado TR, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation. 2001;103:2441-2446.
29. Kim JK, Kim YJ, Fillmore JF, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 2001;108:437-446.
30. Birnbaum MJ. Turning down insulin signaling. J Clin Invest. 2001;108:655-659.
31. Diaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA [Estudios Cardiologicos Latinoamerica] Collaborative Group. Circulation. 1998;98: 2227-2234.
32. Malmberg K, Ryden L, Hamsten A, et al. Effects of insulin treatment on cause- specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J. 1996;17:1337-1344.
33. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.